MedPath

Watermelon and Beetroot Products on Endothelial Function

Not Applicable
Completed
Conditions
Older People With Cardiovascular Disease Risk
Healthy Young
Interventions
Dietary Supplement: Placebo
Dietary Supplement: Watermelon
Dietary Supplement: Watermelon + beetroot
Dietary Supplement: Beetroot
Registration Number
NCT04781595
Lead Sponsor
Universidade Federal do Rio de Janeiro
Brief Summary

Cardiovascular disease is the main cause of death worldwide. Endothelial dysfunction is the first step to development of cardiovascular diseases. Endothelial dysfunction occurs due to reduction in nitric oxide, a molecule that plays an important role on vascular health. Due to important role of nitric oxide in endothelial function, several studies have evaluated the effect of its precursors, such as L-citrulline and nitrate on endothelial function parameters. The present study will evaluate the effect of L-citrulline and nitrate derived by watermelon and beetroot products, respectively, on endothelial function of young and older participants. Furthermore, we will evaluate the plasmatic amino acids, nitrate, glucose and insulin in response to ingestion of these products.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
12
Inclusion Criteria

Not provided

Exclusion Criteria
  • Elevated fasting glucose (≥100 mg/dL);
  • Smoking;
  • Beetroot or watermelon allergy;
  • Unwillingness to avoid beetroot or watermelon products during the entire study;
  • Other chronic diseases (diabetes, liver disease, etc.) or acutely ill

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
PlaceboPlaceboMaltodextrin
WatermelonWatermelonWatermelon powder containing 3 g of L-citrulline.
Watermelon + beetrootWatermelon + beetrootWatermelon powder containing 3 g of L-citrulline and Beetroot powder containing 8 mmol of nitrate.
BeetrootBeetrootBeetroot powder containing 8 mmol of nitrate.
Primary Outcome Measures
NameTimeMethod
Flow-mediated dilation (FMD)This measure will be evaluate 120 minutes after the nutritional intervention
Muscle oxygen saturationThis measure will be evaluate 120 minutes after the nutritional intervention
Secondary Outcome Measures
NameTimeMethod
Plasmatic amino acidsThis measure will be evaluate 120 minutes after the nutritional intervention
Plasmatic insulinThis measure will be evaluate 120 min after the nutritional intervention
Plasmatic glucoseThis measure will be evaluate 120 min after the nutritional intervention

Trial Locations

Locations (1)

Universidade Federal do Rio de Janeiro

🇧🇷

Macaé, Rio De Janeiro, Brazil

© Copyright 2025. All Rights Reserved by MedPath